A new report by Milliman shows that over the 10-year period 2022-2031, if all manufacturer rebates were reflected at the point-of-sale in Medicare Part D, total beneficiary premiums could increase by an estimated $28.7 billion (16%) and total Federal government spending could increase by an estimated $59.5 billion.
Pharmaceutical Care
Management Association
325 7th Street, NW
Washington, DC 20004
Main: 202.756.5700
©2024 PCMA. All Rights Reserved.